171 related articles for article (PubMed ID: 36318305)
21. Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients.
Brown JE; Cook RJ; Lipton A; Coleman RE
Clin Cancer Res; 2012 Nov; 18(22):6348-55. PubMed ID: 22952345
[TBL] [Abstract][Full Text] [Related]
22. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
23. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
24. Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins.
Zhuang L; Scolyer RA; Murali R; McCarthy SW; Zhang XD; Thompson JF; Hersey P
Mod Pathol; 2010 Jan; 23(1):45-53. PubMed ID: 19838163
[TBL] [Abstract][Full Text] [Related]
25. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
[TBL] [Abstract][Full Text] [Related]
26. Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein.
Henry L; Fabre C; Guiraud I; Bastide S; Fabbro-Peray P; Martinez J; Lavabre-Bertrand T; Meunier L; Stoebner PE
Int J Cancer; 2013 Jul; 133(1):142-8. PubMed ID: 23238767
[TBL] [Abstract][Full Text] [Related]
27. Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma.
Diem S; Kasenda B; Spain L; Martin-Liberal J; Marconcini R; Gore M; Larkin J
Br J Cancer; 2016 Feb; 114(3):256-61. PubMed ID: 26794281
[TBL] [Abstract][Full Text] [Related]
28. Comparing the associations between host and tumor factors with survival outcomes with anti-PD-1 immunotherapy in metastatic melanoma.
Koczka K; Rigo R; Batuyong E; Cook S; Asad M; Vallerand I; Suo A; Wang E; Cheng T
Cancer Med; 2023 Feb; 12(3):2427-2439. PubMed ID: 35924450
[TBL] [Abstract][Full Text] [Related]
29. Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.
Mezquita L; Auclin E; Ferrara R; Charrier M; Remon J; Planchard D; Ponce S; Ares LP; Leroy L; Audigier-Valette C; Felip E; Zerón-Medina J; Garrido P; Brosseau S; Zalcman G; Mazieres J; Caramela C; Lahmar J; Adam J; Chaput N; Soria JC; Besse B
JAMA Oncol; 2018 Mar; 4(3):351-357. PubMed ID: 29327044
[TBL] [Abstract][Full Text] [Related]
30. Prognostic score for patients with advanced melanoma treated with ipilimumab.
Diem S; Kasenda B; Martin-Liberal J; Lee A; Chauhan D; Gore M; Larkin J
Eur J Cancer; 2015 Dec; 51(18):2785-91. PubMed ID: 26597444
[TBL] [Abstract][Full Text] [Related]
31. Importance of glycolysis and oxidative phosphorylation in advanced melanoma.
Ho J; de Moura MB; Lin Y; Vincent G; Thorne S; Duncan LM; Hui-Min L; Kirkwood JM; Becker D; Van Houten B; Moschos SJ
Mol Cancer; 2012 Oct; 11():76. PubMed ID: 23043612
[TBL] [Abstract][Full Text] [Related]
32. The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis.
Stark MS; Klein K; Weide B; Haydu LE; Pflugfelder A; Tang YH; Palmer JM; Whiteman DC; Scolyer RA; Mann GJ; Thompson JF; Long GV; Barbour AP; Soyer HP; Garbe C; Herington A; Pollock PM; Hayward NK
EBioMedicine; 2015 Jul; 2(7):671-80. PubMed ID: 26288839
[TBL] [Abstract][Full Text] [Related]
33. Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy.
Weide B; Richter S; Büttner P; Leiter U; Forschner A; Bauer J; Held L; Eigentler TK; Meier F; Garbe C
PLoS One; 2013; 8(11):e81624. PubMed ID: 24312329
[TBL] [Abstract][Full Text] [Related]
34. Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study.
Thenappan T; Stulak JM; Agarwal R; Maltais S; Shah P; Eckman P; Emani S; Katz JN; Gregoric I; Keebler ME; Uriel N; Adler E; Chuang J; Farrar DJ; Sundareswaran KS; John R
J Heart Lung Transplant; 2018 Jan; 37(1):25-32. PubMed ID: 29153636
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of multiple serum markers in advanced melanoma.
Díaz-Lagares A; Alegre E; Arroyo A; González-Cao M; Zudaire ME; Viteri S; Martín-Algarra S; González A
Tumour Biol; 2011 Dec; 32(6):1155-61. PubMed ID: 21858537
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of serum lactate dehydrogenase in patients undergoing radical cystectomy for bladder cancer.
Su S; Liu L; Sun C; Yang L; Nie Y; Chen Y; Zhang J; Li S
Urol Oncol; 2020 Nov; 38(11):852.e1-852.e9. PubMed ID: 32624424
[TBL] [Abstract][Full Text] [Related]
37. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.
Ishihara K; Saida T; Otsuka F; Yamazaki N;
Int J Clin Oncol; 2008 Feb; 13(1):33-41. PubMed ID: 18307017
[TBL] [Abstract][Full Text] [Related]
38. Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation.
Muchtar E; Dispenzieri A; Lacy MQ; Buadi FK; Kapoor P; Hayman SR; Gonsalves W; Warsame R; Kourelis TV; Chakraborty R; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Dingli D; Leung N; Rajkumar SV; Kyle RA; Kumar SK; Gertz MA
Br J Haematol; 2017 Sep; 178(6):888-895. PubMed ID: 28699650
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of lactate dehydrogenase and serum S100 levels in stage IV melanoma with known BRAF mutation status.
Frauchiger AL; Mangana J; Rechsteiner M; Moch H; Seifert B; Braun RP; Dummer R; Goldinger SM
Br J Dermatol; 2016 Apr; 174(4):823-30. PubMed ID: 26659191
[TBL] [Abstract][Full Text] [Related]
40. Using Both Lactic Dehydrogenase Levels and the Ratio of Involved to Uninvolved Free Light Chain Levels as Risk Factors Improves Risk Assessment in Patients With Newly Diagnosed Multiple Myeloma.
Guo Z; Li H; Geng Y; Cui J; Tang N; Li D
Am J Med Sci; 2018 Apr; 355(4):350-356. PubMed ID: 29661348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
